Henry Jungnickel

Learn More
BACKGROUND In nonrandomized trials, neoadjuvant treatment was reported to prolong survival in patients with pancreatic cancer. As neoadjuvant chemoradiation is established for the treatment of rectal cancer we examined the value of neoadjuvant chemoradiotherapy in pancreatic cancer in a randomized phase II trial. Radiological staging defining resectability(More)
(2014) Neoadjuvant chemoradiation therapy with Strahlentherapie und Onkologie, Suppl. data 1 gemcitabine/ cisplatin and surgery versus immediate surgery in resectable pancreatic cancer. Results of the first prospective randomized phase II trial. (ISRCTN78805636). This is the extended version of the manuscript " Golcher H, Brunner TB, et al (2014)(More)
  • 1